Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parallel Group, Placebo-Controlled, Tolerability and Safety Study of Thioctic Acid and Deprenyl in HIV Dementia

NCT00002154 is registered in ClinicalTrials.gov with The Dana Foundation as lead sponsor.

NCT NCT00002154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parallel Group, Placebo-Controlled, Tolerability and Safety Study of Thioctic Acid and Deprenyl in HIV Dementia
Lead sponsor
The Dana Foundation
Phase
Phase 2
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
32
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive disorders, hiv infections